¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Ascorbic Acid type SC"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 14
  • ¿µ¹®
    ÇѱÛ
  • propanoic acid
    ÇÁ·ÎÆÇ»ê
  • propionic acid
    ÇÁ·ÎÇǿ»ê
  • pyridoxic acid
    ÇǸ®µ¶½Å»ê
  • pyrophosphoric acid
    ÇÇ·ÎÀλê
  • pyruvic acid
    ÇÇ·çºê»ê
  • periodic acid-Schiff stain
    PAS¿°»ö
  • palmitic acid
    ÆÈ¹ÌÆ®»ê
  • retinoic acid
    ·¹Æ¼³ë»ê
  • ribonucleic acid
    ¸®º¸ÇÙ»ê, RNA
  • saccharic acid
    »çÄ«¸°»ê
  • saturated fatty acid
    Æ÷È­Áö¹æ»ê
  • sorbic acid
    ¼Ò¸£ºê»ê
  • spermanucleic acid
    Á¤ÀÚÇÙ»ê
  • stearic acid
    ½ºÅ׾Ƹ£»ê
  • succinic acid
    ¼÷½Å»ê
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 14
  • ¿µ¹®
    ÇѱÛ
  • trichloroacetic acid
    »ï¿°È­¾Æ¼¼Æ®»ê
  • unsaturated fatty acid
    ºÒÆ÷È­Áö¹æ»ê
  • uric acid
    ¿ä»ê
  • uridine diphosphate glucuronic acid
    ÀÌÀλêÀ¯¸®µò±Û·çÄí·Ð»ê
  • urocanic acid
    À¯·ÎÄ«´Ñ»ê
  • uronic acid
    À¯·Ð»ê
  • ursodeoxycholic acid
    ¿ì¸£¼Òµð¿Á½ÃÄݸ°»ê
  • volatile acid
    Èֹ߼º»ê
  • boric acid ointment
    ºØ»ê¿¬°í
  • carbolic acid gangrene
    ¼®Åº»ê±«Àú
  • citric acid cycle
    ±¸¿¬»êȸ·Î, ½ÃÆ®¸£»êȸ·Î
  • tricarboxylic acid cycle
    »ïÄ«¸£º¹½Ç»êȸ·Î
  • nucleic acid hybridization
    ÇÙ»êºÎÇÕÈ­
  • uric acid infarct
    ¿ä»ê°æ»ö
  • nucleic acid probe
    ÇÙ»ê´õµëÀÚ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 14
  • ¿µ¹®
    ÇѱÛ
  • general acid
    ÀϹݻê(ìéÚõß«).
  • glacial acetic acid
    ºùÃÊ»ê.
  • glucosidase, alpha-glucosidase(acid maltase)
    -±Û·çÄڽõ¥À̽º, -glucosidase
  • glucuronic acid
    ±Û·çÄí·Ð»ê.
  • glucuronic acid pathway
    ±Û·çÄí·Ð»ê°æ·Î.
  • glutamic acid
    ±Û·çŽ»ê.
  • glutamic acid dehydrogenase
    ±Û·çŽ»êÅ»¼ö¼ÒÈ¿¼Ò, ±Û·çŽ»êµ¥È÷µå·Î°Ô<³ª>Á¦.
  • glutaric acid
    ±Û·çŸ¸£»ê.
  • glyceric acid
    ±Û¸®¼¼¸°»ê(¡­ß«).
  • glyceroboric acid
    ±Û¸®¼¼¸£ºØ»ê
  • glycocholic acid
    ±Û¸®ÄÚÄÝ»ê.
  • glycolic acid
    ±Û¶óÀÌÄÝ»ê
  • gout,uric acid stones
    ¿ä»ê°á¼®
  • guanylic acid deaminase
    ±¸¾Æ´Ò»êµ¥¾Æ¹Ì³ª Á¦.
  • heat and acetic acid test
    °¡¿Â¾Æ¼¼Æ®»ê½ÃÇè (¹ý)(ʥ计­ß«ãËúÐÛö).
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 14
  • ¿µ¹®
    ÇѱÛ
  • type of respiration
    È£ÈíÇü(û¼ýåúþ).
  • type species
    Ç¥ÁرÕÁ¾(øöñÞжðú).
  • type specific antigen
    ÇüƯÀÌÇ׿ø
  • type specific polysaccharide
    ÇüƯÀ̼º ´Ù´ç·ù(úþ÷åì¶àõÒýӨ׾).
  • type specificity
    ÇüƯÀ̼º
  • type strain
    ´ëÇ¥±ÕÁ¾(ÓÛøúжðú), Ç¥ÁرÕÁ¾(øöñÞжðþ).
  • type strain
    ´ëÇ¥±ÕÁ¾(ÓÛøúжðú), Ç¥ÁرÕÁ¾(øöñÞжðþ).
  • type, nomenclatural
    ºÐ·ùÇÐÀû ±âÁظí
  • type, phage
    ÆÄÁöÇü
  • type, wild
    ¾ß»ýÇü, ¾ß»ýÁÖ
  • undulant type
    ÆÄ»óÇü(÷îßÒúþ).
  • unstable type
    ºÒ¾ÈÀüÇü(ÝÕäÌïÒúþ).
  • water in oil type
    À¯Áß¼öÀûÇü(êúñéâ©îÙúþ).
  • well-type ionization chamber
    ¿ì¹°ÇüÀü¸®ÇÔ
  • wild type
    ¾ß»ýÇü(å¯ßæúþ).
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 14
  • ¿µ¹®
    ÇѱÛ
  • hyaluronic acid
    ÇÏÀ̾ËÀ¯·Ð»ê(ß«)
  • hydroxy acid
    ÇÏÀ̵å·Ï½Ã»ê(ß«)
  • ¥â-hydroxybutyric acid
    ¥â-ÇÏÀ̵å·Ï½ÃºäƼ¸£»ê(ß«)
  • 5-hydroxyindoleacetic acid
    5-ÇÏÀ̵å·Ï½ÃÀε¹¾Æ¼¼Æ®»ê(ß«)
  • imino acid
    À̹̳ë»ê(ß«)
  • indispensable amino acid
    ºÒ°¡°á(ÝÕʦÌÀ) ¾Æ¹Ì³ë»ê(ß«)
  • indoleacetic acid
    Àε¹¾Æ¼¼Æ®»ê(ß«)
  • infectious nucleic acid
    °¨¿°¼ºÇÙ»ê(Êïæøàõú·ß«)
  • inosinic acid
    À̳ë½Å»ê(ß«)
  • isoascorbic acid
    ¾ÆÀ̼ҾƽºÄÚ¸£ºó»ê
  • isocitric acid
    ¾ÆÀ̼һçÀÌÆ®¸£»ê(ß«)
  • iso fatty acid
    ¾ÆÀ̼ÒÁö¹æ»ê(ò·Û¸ß«)
  • isonicotinic acid hydrazide
    ¾ÆÀ̼ҴÏÄÚÆ¾»ê(ß«) ÇÏÀ̵å¶óÁöµå
  • ketogenic amino acid
    ÄÉÅæ»ý¼º(ßæà÷) ¾Æ¹Ì³ë»ê(ß«)
  • -ketoglutaric acid
    -ÄÉÅ䱸¸£Å¸¸£»ê(ß«)
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 14
U-RNA uridylic acid ribonucleic acid
DMD Duchenne type Muscular Dystrophy; ¾Ç¼ºÇü DuchenneÇü ±ÙÀÌ¿µ¾çÁõ
EA   1) Esophageal Atresia
  Types
  1. Esophageal Atresia with Dis...
GIDAANT Gender Identity Disorder of Adolescence or Adulthood, Non-transsexual Type
HBPV Haemophilus influenza type B Polysaccharide(PRP) Vaccine; BÇü Çì¸ðÇʷ罺 ÀÎÇ÷翣ÀÚ ÇǸ· ´Ù´çÁú ¹é½Å...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 14
CAV-1 Canine adenovirus type 1
CAV-2 Canine adenovirus type 2
CPV-2 Canine parvovirus type 2
CRBP(II) Cellular retinol-binding protein type II
CMT1 Charcot--Marie--Tooth disease type 1
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 14
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • mucosal barrier to acid back-diffusion

    mucosal bleeding (Á¡¸· ÃâÇ÷

  • mycolic acid
    ¹ÌÄÝ»ê.
  • N-Benzol-L-tyrosyl-p-aminobenzoic acid
    N-º¥Á¹-L-Ƽ·Î½Ç-p-¾Æ¹Ì³ë ¾È½ÄÇâ»ê
  • nalidixic acid
    ³¯¸®µñ½º»ê
    C
  • naphthalenesulfonic acid
    ³ªÇÁÅ»·» ¼úÆù»ê
    ³ªÇÁÅ»·»À» ¼úÆùÈ­½ÃŰ¸é »ý±â´Â È­ÇÕ¹°. 1-³ªÇÁÅ»·» ¼úÆù»ê°ú 2-³ªÇÁÅ»·» ¼úÆù»êÀÇ µÎ À̼ºÁúü°¡ ÀÖ´Ù. ÀüÀÚ´Â 60 ¡É ÀÌÇÏÀÇ ¹ÝÀÀ ¿Âµµ¿¡¼­ ¾òÀ» ¼ö ÀÖ°í, ÈÄÀÚ´Â 165 ¡É¿¡¼­ ¾òÀ» ¼ö ÀÖ´Ù. ¾ËÄ®¸® À¶ÇØÇÏ¸é ³ªÇÁÅçÀ» ¾ò´Â´Ù. ³ªÇÁÅ»·»À» ¿ø·á·Î ÇÏ´Â ¿°·á´Â ´ëºÎºÐ ³ªÇÁÅ»·» ¼úÆù»êÀ» °ÅÃÄ ÇÕ¼ºµÇ¹Ç·Î ¿°·á °ø¾÷¿¡ ¸Å¿ì Áß¿äÇÏ´Ù. ¸ð³ë ¼úÆù»êÀ» ´Ù½Ã ¼úÆùÈ­Çϸé Á¶°Ç¿¡ µû¶ó ¿©·¯ ¼úÆù»êÀÌ »ý±ä´Ù. ¶Ç ³ªÇÁÅç ¼úÆù»êÀÇ ¾Æ¹Ì³ë À¯µµÃ¼, ³ªÇÁÅç ¼úÆù»ê µîÀÌ ¿°·á Áß°£Ã¼·Î¼­ ¸¹ÀÌ »ý¼ºµÈ´Ù.
  • Newton's method for uric acid
    ´º¿ìư ¿ä»ê Á¤·®¹ý
    »ê¼º ¿°È­Àº ħÀü¹ý¿¡ ÀÇÇØ °£¼· ¹°ÁúÀ» Á¦°ÅÇϰí, û»ê¿°À» È¥ÇÕÇÑ Çǰ˾×À» ºñ¼Ò ÅÖ½ºÅÙ ½Ã¾àÀ» 24½Ã°£ ½Ç¿Â¿¡¼­ ¹ÝÀÀ½ÃÄÑ ºñ»öÇÑ´Ù.
  • Nissl's acid
    ´Ï½½»ê
    »ê¼º¾× ¶Ç´Â ¾Ï¸ð´Ï¾Æ¿¡ ³ì´Â´Ù.
  • nitrobenzoic acid
    ´ÏÆ®·Î ¾È½ÄÇâ »ê
    NO2C6H4COOH. ´ÏÆ®·Î Åç·ç¿ÃÀÌ »êÈ­µÇ¾î »ý±â´Â È­ÇÕ¹°.
  • nitroferrocyanic acid
    ´ÏÆ®·Î Æä·Î½Ã¾È»ê
    H2[Fe
  • octanoic acid
    ¿ÁÅ×Àλê
  • oleic acid
    ¿Ã·¹»ê
    µ¿½Ä¹°¿¡ ³Î¸® Á¸ÀçÇÏ´Â Áö¹æ»ê. È­ÇÐ½Ä C8H4O, ³ì´ÂÁ¡ 12 ¡É, ²ú´ÂÁ¡ 360 ¡ÉÀÌ´Ù. ÀÌÁß °áÇÕÀ» 1°³ °¡Áö´Â ºÒÆ÷È­ Áö¹æ»êÀÌ´Ù. ¹°¿¡´Â °ÅÀÇ ³ìÁö ¾ÊÀ¸³ª, ¿¡Åº¿Ã, ¿¡Å׸£, Ŭ·Î·ÎÆ÷¸§ µî¿¡´Â ³ì´Â´Ù. ¹é±ÝÈæ, ´ÏÄÌ µîÀ» Ã˸ŷΠÇÏ¿© ¼ö¼Ò·Î ȯ¿ø½ÃŰ¸é Æ÷È­ÀÎ ½ºÅ׾Ƹ£»êÀÌ µÈ´Ù. ¼ø¼öÇÑ °ÍÀº ¹«»ö, ¹«ÃëÀÎ À¯»ó ¾×üÀ̳ª, °ø±â ¼Ó¿¡ ¹æÄ¡ÇØ µÎ¸é »êÈ­µÇ¾î Ȳ»ö ¶Ç´Â °¥»öÀ¸·Î Âø»öµÇ°í ½â´Â ³¿»õ°¡ ³­´Ù. µ¿¹°¿¡¼­´Â ±Û¸®¼¼¸°°ú ¿¡½ºÅ׸£¸¦ Çü¼ºÇÏ¿© ÇÇÇÏ Áö¹æÀ̳ª °£¿¡ ÀúÀåµÈ´Ù. °ø¾÷ÀûÀ¸·Î ¿ëµµ°¡ ³ÐÀ¸¸ç, ºñ´©ÀÇ ¿ø·á³ª õÀÇ ¹æ¼öÁ¦·Î¼­ ÀÌ¿ëµÈ´Ù.
  • ophthalmic acid
    ¿ÀÇÁÅ»¹Î»ê
    ¼ÒÀÇ ¼öÁ¤Ã¼ Áß¿¡ Á¸ÀçÇÏ´Â Æ®¶óÀÌ ÆéŸÀ̵å.
  • organic acid
    À¯±â»ê
    1. ¿øÀÚ´ÜÀÌ Åº¼Ò À¯µµÃ¼ÀÎ »ê. źȭ¼ö¼Ò±â°¡ COOH³ª SO3H¿Í °áÇÕÇϰí ÀÖ´Â È­ÇÕ¹°. 2. »ê¼ºÀ» ¶ì´Â À¯±âÈ­ÇÕ¹°ÀÇ ÃÑĪ. ¹«±â»ê°ú ´ëÀÀÇÏ´Â ¸»·Î¼­ ¾Æ¼¼Æ®»ê, ºÎƼ¸£»ê, ÆÈ¹ÌÆ®»ê, ¿Á»ì»ê, Ÿ¸£Å¸¸£»ê µîÀÌ ÀÖ´Ù. ±× ´ëºÎºÐÀº Ä«¸£º¹½Ã»êÀ̹ǷΠÁ¼Àº ¶æÀ¸·Î´Â Ä«¸£º¹½Ã»êÀ» °¡¸®Å²´Ù. ±×·¯³ª ¾Æ½ºÄÚ¸£ºê»êÀ̳ª ¿ä»ê
  • oxalacetic acid
    ¿Á»ì¾Æ¼¼Æ®»ê
  • pantotheic acid
    ÆÇÅäÅÙ»ê
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 14
type VII mucopolysaccharidosis <syndrome> An autosomal recessive disorder due to a deficiency of a beta-glucuronidase; defective lysosomal degradation of dermatan sulfate, heparan sulfate, and chondroitin sulfate; cellular function disrupted in most tissues.
Synonym: type VII mucopolysaccharidosis, type VIII mucopolysaccharidosis.
(05 Mar 2000)
type VI mucopolysaccharidosis <biochemistry, syndrome> An error of mucopolysaccharide metabolism due to deficiency of the lysosomal enzyme arylsulphatase B.
It is characterised by excretion of dermatan sulfate in the urine, growth retardation, lumbar kyphosis, sternal protrusion, genu valgum, usually hepatosplenomegaly, and no mental retardation.
Onset occurs after two years of age.
Inheritance: autosomal recessive.
Synonym: polydystrophic dwarfism, mucopolysaccharidosis type VI.
(05 Mar 2000)
type V mucopolysaccharidosis Former designation for Scheie's syndrome.
(05 Mar 2000)
Farr type assay <investigation> Method of radioimmunoassay in which free antigen remains soluble and antibody antigen complexes are precipitated.
(18 Nov 1997)
undifferentiated type fever A term applied to illnesses resulting from infection by any one of the arboviruses pathogenic for man, in which the only constant manifestation is fever; rash, lymphadenopathy, or arthralgia (alone or in combination) may occur in some individuals but not in others; some arboviruses may induce infections in which undifferentiated type fever is the only manifestation, whereas other arboviruses may induce in some persons only undifferentiated fever, and in other persons similar fever followed by secondary manifestations, e.g., a haemorrhagic fever or encephalitis.
(05 Mar 2000)
"e"-type cholinesterase <enzyme, neurology, physiology> An enzyme that breaks down unused acetylcholine in the synaptic cleft (the space between neurons), this enzyme is necessary to restore the synaptic cleft so it is ready to transmit the next nerve impulse.
(06 May 1997)
Langhans'-type giant cells Multinucleated giant cell's seen in tuberculosis and other granulomas; the nuclei are arranged in an arciform manner at the periphery of the cell's.
Synonym: Langhans'-type giant cells.
Synonym: cytotrophoblastic cells.
(05 Mar 2000)
Laron type dwarfism Dwarfism associated with an absent or very low levels of somatomedin C (insulin-like growth factor I) or abnormalities in receptor activity.
(05 Mar 2000)
F-type ATPase <enzyme> One of three major classes of ion transport ATPase, characterised by a multi subunit structure and a lack of a phosphorylated intermediate.
See: ATP synthase, P-type ATPase, V-type ATPase.
(18 Nov 1997)
a1-acid glycoprotein <biology> Plasma protein of mammals and birds, 38% carbohydrate. In humans a single chain glycoprotein of 39 kD. Increased levels are associated with inflammation, pregnancy and various diseases.
(18 Nov 1997)
abscisic acid <biochemistry> A lipid hormone that inhibits cell growth in plants, it is associated with fruit drop, leaf death and seed dormancy. It is synthesised in the plastids from carotenoids. This hormone helps plants deal with water loss, and its effects can be reversed with gibberellins.
(06 May 1997)
abscisic acid 8'-hydroxylase <enzyme> Catalyses conversion of abscisic acid to 8'-hydroxyabscisic acid, which rearranges to phaseic acid
Registry number: EC 1.14.99.-
Synonym: aba 8'-hydroxylase
(26 Jun 1999)
acetic acid <chemical> The acid most commonly associated with vinegar, it is the most commercially important organic acid and is used to manufacture a wide range of chemical products, such as plastics and Acetobacter but, except for making vinegar, is usually made through synthetic processes.
Derivatives of acetic acid which may be formed by substitution reactions. Mono- and di-substituted, as well as, halogenated compounds have been synthesised.
Experimentally, alpha- and n2- substituted acetic acids have been examined for their anti-inflammatory activity and effect on the central nervous system respectively. Additionally, limited exposure data has been collected on dibromo and dichloroacetic acids to determine whether they pose health effects.
Synonym: ethanoic acid.
(26 Jun 1999)
acetoacetic acid CH3COCH2COOH;one of the ketone bodies, formed in excess and appearing in the urine in starvation or diabetes.
Synonym: diacetic acid.
(05 Mar 2000)
acetohydroxamic acid C2H5NO2; N-Hydroxyacetamide;an inhibitor of urease, used as adjunctive therapy in chronic urea-splitting urinary infections.
(05 Mar 2000)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 14
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 14
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 14
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 14
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 14
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 14
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 14
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 14
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 14
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 14
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 14
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 14
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 14
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 14
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 14
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 14
ÅëÇÕ°Ë»ö ¿Ï·á